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ABSTRACT
The aim of this study was to analyze the effect of torbangun leaves powder capsules supplementation on 
lipid profile and blood pressure in men with hypercholesterol. This study was a single blind randomized 
control trial design with 26 male subjects. The inclusion criterias for subject were adults (age 25-55 years), 
blood total cholesterol levels ≥200 mg/dl, and signed the informed consent. Subjects were divided into 
two groups of one intervention (torbangun capsules) and one control (amylum) group. The intervention 
of 750 mg/day torbangun powder for the intervention group and 300 mg/day amylum for control group 
were administered for 28 days. The analysis of lipid profile results showed that the trygliseride, LDL, 
and HDL were not significantly affected by the torbangun intervention but it significantly decreased 
the total cholesterol level. The supplementation of torbangun capsules also decreased the sistolic blood 
pressure significantly, but not in diastolic pressure. 
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INTRODUCTION
Health, education, and work productivi-
ty are important indicators for progress in de-
velopment, advancement in those indicators are 
highly influenced by nutritional status. Regarding 
health and productivity, non-optimal nutritional 
status may cause health problems, especially 
non-infectious disease such as cardiovascular di-
seases (coronary heart disease, hypertension, and 
stroke), cancer, and diabetes. Better nutrition lead 
to better health through the maintenance of nor-
mal weight and increase immunity thus increas-
ing work productivity, and protecting the body 
from chronic disease and early death (Syam et al. 
2013).
There has been a big shift in disease burden 
from infectious diseases to non-infectious ones. 
More than 38 million people globally died from 
non-infectious disease. Cardiovascular disease 
(CVD) has become the main cause for death in 
various part of the world, including in Indonesia. 
Latest statistics in Indonesia pointed that CVD 
was accounted for as much as 37% from all death 
cases (WHO 2014). Death caused by cardiovas-
cular disease, mainly coronary heart disease and 
stroke, is predicted to increase and reaching 23.3 
million deaths in 2030 (Kemenkes RI 2014).
The common pathophysiology of cardio-
vascular disease such as coronary heart disease 
(CHD) begins with atherosclerosis plaque for-
mation and hypertension. The cause of this athe-
rosclerosis and hypertension are various, such 
as high levels of plasma total cholesterol, age, 
smoking habit, obesity, stress, diabetes melli-
tus, cholesterol, fat from food consumption, and 
dyslipidemia (Hu et al. 2001). Dyslipidemia, a 
condition where the metabolism of lipid is abnor-
mal indicated by the increasing or decreasing of 
lipid fraction in plasma is one of the main risk 
for CHD. Thus blood lipid profile comprising of 
triglyceride, total cholesterol, LDL (Low Den-
sity Lipoprotein) cholesterol, and HDL (High 
Density Lipoprotein) cholesterol levels are often 
utilized as CHD risk parameters (Djohan 2004). 
Hence treating dyslipidemia will lower the risk 
for CHD. 
Many studies on plants or natural resour-
ces’ benefits for dyslipidemia and hypertension 
treatment have been reported in many countries 
(Lukacinova et al. 2008; Hsieh et al. 2010; Atef 
2011; Batubara et al. 2012; Guo et al. 2014; Gen-
gatharan et al. 2015; Herrera et al. 2016). In In-
donesia, there are still many plants that have not 
been scientifically studied although people have 
utilized them for years as part of the local wis-
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dom. One such plants is torbangun (Coleus am-
boinicus Lour). 
Torbangun contains antioxidant, vitamin 
C, B1, B12, beta carotene, niacin, carvacrol, 
calcium, fatty acids, oxalate acid, and dietary fi-
ber (Viswanathaswamy et al. 2011; Nadernejad 
et al. 2012). Helmizar (2010) stated that higher 
consumption of antioxidant significantly showed 
better levels of triglyceride, LDL, HDL, and total 
cholesterol. In addition, consumption of vege-
tables and fruits which are rich in dietary fiber, 
vitamin, mineral, and antioxidant may prevent 
degenerative diseases, mainly caused by blood 
pressure and cholesterol (Depkes RI 2007). An-
tioxidant plays a role in controlling the oxidative 
stress as biostimulator to increase the function of 
pancreas β-cells and insulin sensitivity, so that 
it prevents metabolic disorder syndrome. Torba-
ngun’s antioxidant which are flavonoid, terpe-
noid, and saponin as well as its ascorbic acid con-
tent obstructs the oxidative stress resulting in the 
hypoglycemic and hypocholesterolemia effects 
(Shenoy et al. 2012).
Batubara et al. (2012) mentioned that 
mineral contents in torbangun leaves are calci-
um, potassium, magnesium, iron, α-tocopherol, 
β-carotene, essential oil, phenol, thymol, carva-
crol, phorscoline, isopropyl ocresol, sinerol, fla-
vonoids, and glycoside. Biological activities from 
those compounds as antioxidant, diuretic, analge-
sic, anti-cancer, anti-tumor, anti-vertigo, immu-
nostimulator, anti-inflammation, anti-infertility, 
hypocholesterolemic agent, hypotensive agent, 
and other benefits still requires further study (Ro-
shan et al. 2010). A research conducted by Viswa-
nathaswamy et al. (2011) reported that torbangun 
leaves extract has shown an anti-hyperglycemia 
and anti-hyperlipidemia activities by ameliora-
ting carbohydrate and fat metabolism disorder, 
and by improving the concentration of intracel-
lular calcium in mice. Suryowati et al. (2015) 
reported that the ethanol extract of torbangun 
leaves has the potential to be a biostimulator for 
improvement in blood lipid profile in mice with 
type 2 of diabetes.
Andriani et al. (2012) highlighted that tor-
bangun leaves capsule significantly preserved the 
cholesterol total in normal condition of healthy 
subjects. Alvianti’s research (2015) also proved 
that subjects who consume torbangun capsule 
and fishes in 28 days significantly had lower 
blood pressure compared to ones consuming fish-
es without torbangun capsule.
Many researches on the potential and 
contents of torbangun have been conducted, but 
research to obtain information on its benefit to 
lipid profile is still limited to animal test. Previ-
ous research on human only observed its effect 
on healthy subjects and have not encompassed a 
comprehensive lipid profile change, so this un-
derlay the purpose of this research to obtain in-
formation about torbangun effects on subjects 
with hypercholesterolemia. The purposes of this 
research were 1) to understand the differences 
of subject’s characteristics that can act as con-
founding factors for the research; 2) to analyze 
the effect of torbangun powder capsule supple-
mentation towards blood lipid profile (cholesterol 
total, triglyceride, LDL, and HDL) of adult male 
subjects with hypercholesterolemia; 3) to analyze 
the effect of torbangun powder capsule supple-
mentation towards blood pressure (systolic and 
diastolic) of adult male subjects with hypercho-
lesterolemia.
METHODS
Design, locaion, and time
The study design was experimental. This 
research was conducted from January to June 
2017. Torbangun powder was made in Southeast 
Asian Food and Agricultural Science and Tech-
nology (SEAFAST) Center IPB laboratory. The 
capsule making was conducted in Liza Herbal 
Indonesia. Next, intervention capsule distribution 
was conducted in rectorate building in IPB. The 
analysis of blood lipid profile was conducted in 
Labkesda (Regional’s health laboratory) Bogor. 
Sampling
Sample populations in this research were 
non-academic staff of Bogor Agricultural Uni-
versity. They were chosen purposively by ap-
plying the inclusion and exclusion criteria. In-
clusion criteria of  research’s subject were adult 
man aged 25-55 years old; cholesterol levels of 
≥200 mg/dl; healthy; never drink alcohol, any 
supplements, traditional or any herbal medicines; 
never consume any drugs that lowering choles-
terol level routinely, willing to fill the informed 
consent and willing to participate in the research 
until the end. The exclusion criteria were having 
serious illness, had to be hospitalized or consum-
ing certain medicines routinely, and participating 
in another researches.
This research has obtained the ethical ap-
proval from Medical Ethic Commission Number 
of 585/UN2.F1/ETIK/2017, Faculty of Medicine, 
University of Indonesia.
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Subjects were divided into two groups, 
one was intervention group that given torbangun 
capsule and control group given amylum cap-
sule. The subjects for this study were 13 people 
for each group, so that the total subjects were 26 
people. The sample size determination was calcu-
lated using the Lameshow et al. (1997) formula.
Before being encapsulated, analysis was 
conducted on torbangun powder including mois-
ture content, nutrient content of macro substances 
as well as some vitamins and minerals. A hundred 
gram of torbangun powder contained 9.8% water, 
14.1% ash, 25.7 g protein, 7.4 g fat, 41.9 g car-
bohydrate, 72.5 mg iron, 3911.9 mg magnesium, 
472.6 mg calcium, and 67.7 mg vitamin C. The 
production method and nutrition content were in 
accordance with research conducted by Andriani 
et al. (2012).
The finely-ground torbangun powder was 
then put into 0 (zero) sized capsule with dosage 
of 250 mg per capsule. The dosage used in this 
research was 750 mg torbangun powder each day 
(three capsules). The control group received 300 
mg amylum in capsules, as if it is consumed in 
small amount, it will not give any effect.
Intervention. Before intervention, subjects 
were screening and those who has total choles-
terol ≥200 mg/dl were chosen to be intervened. 
The screening was conducted by health analyst 
on the peripheral blood sample using Easy Touch 
UGC device. Intervention was given for 28 days, 
started a day after the blood sample for pre-inter-
vention lipid profile was taken. 
The intervention group took torbangun 
capsule as many as three capsules per day and 
control group had one amylum capsule per day. 
The supplement was packed in labelled bottles 
and given to subjects three times per day, at the 
same time. Intervention of subjects compliance 
were controlled using questionnaires. During the 
intervention period, researcher was assisted by a 
doctor to anticipate any further complaints oc-
curred from the subjects.
Data analysis
Data were processed using Microsoft Ex-
cel 2013 and analysed SPSS 16.0 version. Sam-
ple characteristic data was analyzed descriptively 
for mean, median, standard deviation, minimum 
value, and maximum value. Observed variables 
were measured before and after intervention on 
each subject according to the group. The Paired 
t-test was used to see the difference of value on 
each group before and after intervention. The In-
dependent t-test was conducted for analyzing the 
different test on each variable between interven-
tion and control groups. The ANCOVA test was 
used to determine the effect of torbangun inter-
vention by controlling covariate variables.
The usage of various levels and expected 
decrease in lipid profile levels referred to Avianti 
(2015).
Data collection
The data collected in this research were 
subjects’ characteristics (age, weight, height, and 
nutrition status based on BMI), life style (smoking 
and exercise habits), lipid profile (total choleste-
rol, triglyceride, HDL, LDL), and blood pressure 
(systolic and diastolic). The data on age and life 
style were collected through interview and ques-
tionnaire. Weight, height, and blood pressure data 
were collected by measuring it directly. Blood 
pressure and lipid profile were measured twice. 
before intervention and after intervention. Lipid 
profile was analyzed from blood taken from sub-
jects’ vein, previously obligated to fast at least 
for 10 hours. The blood taking process was done 
by health personnel from Labkesda (Regional 
Health Laboratory) of Bogor.
Subjects’ weight was measured using digi-
tal scales (Omron), height was measured using 
microtoise. BMI was calculated using the BW 
(kg)/BH2 (m2) formulation. The systolic and dyas-
tolic blood pressure were measured using digital 
bloods pressure monitor, meanwhile lipid profile 
(total cholesterol, triglyceride, HDL, and LDL) 
were analyzed with spectrophotometry method.
Procedures
Production of torbangun powder capsule.
The torbangun powder used for the intervention 
was produced at the beginning of this research. 
The method was started by sorting fresh and 
light green torbangun leaves and soft stems to be 
washed and blanched. Then the leaves were all 
milled with miller and dried by using drum dryer. 
Next, the leaves were all mashed by using disk 
mill and sieved ,sized 60 mesh strainer.
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Subject characteristics
Most of subjects were around 46-55 years 
old. Average weight of all subjects before inter-
vention was 72.5±9.1 kg. Nutrition status assess-
ment based on Body Mass Index (BMI) showed 
that most of subjects were classified as obese with 
BMI of 26.9±2.8 kg/m2 in average. Obesity may 
increase the risk of developing insulin resistance 
and dyslipidemia (Choi et al. 2002). Individual’s 
blood pressure condition is determined by the 
systolic and diastolic blood pressure.  The aver-
age of systolic and diastolic blood pressure in 
control group before the intervention was higher 
that the intervention group, but the independent 
Amalia et al.
t-test did not show the significant difference be-
tween the two groups (p>0.05). Most of subjects' 
condition were pre-hypertension (42.31%) (Ta-
ble 1).
The cholesterol levels before intervention 
in both groups were not significantly different 
(p>0.05) and all subjects were in hypercholester-
olemia with average cholesterol levels was 231.1 
mg/dl. Fifteen subjects were having high levels 
of triglyceride before intervention, meanwhile 
the rest of them were normal (178.0±83.3 mg/
dl) for all subjects. Most subjects (73.08%) had 
low le-vels of HDL and high levels of LDL (25 
people, 95.15%) before intervention.
Subjects involved in this research should 
be in homogenous condition to reduce research 
Tabel 1. The distribution of subjects based on intervention
Variabel Intervention Control Total p
Age (year) 46.9 ±7.2 51.5±3.9 49.19±6.1 0.060 2)
25-35 n  (%) 1 (7.69) 0 (0.00) 1 (3.85)
36-45 n  (%) 3 (23.08) 2 (15.38) 5 (19.2)
46-55 n  (%) 9 (69.23) 11 (84.62) 20 (76.92)
Body Weight (kg) 70.2±8.1 74.0±10.1 72.5±9.1 0.3062)
BMI (kg/m2) 25.8±2.6 27.2±2.9 26.9±2.8 0.2121)
Underweight n (%) 0 (0.00) 0 (0.00) 0 (0.00)
Normal n (%) 4 (31.77) 3 (23.08) 7 (26.92)
Overweight n (%) 4 (31.77) 2 (15.38) 6 (26.08)
Obesity n (%) 5 (38.46) 8 (61.54) 13 (50.00)
Sistolic Blood Pressure (mmHg) 137.8±20.6 142.0±14.3 139.9 ±17.5 0.5571)
Diastolic Blood Pressure (mmHg) 82.2±11.4 82.8±9.1 82.5 ±10.1 0.8951)
Normal n (%) 2 (15.38) 0 (0.00) 2 (7.69)
Pre Hipertentionn (%) 6 (46.15) 5 (38.46) 11 (42.31)
Stadium 1 hipertention n (%) 2 (15.38) 7 (53.85) 9 (34.62)
Stadium 2 hipertention n (%) 3 (23.08) 1 (7.69) 4 (15.38)
Cholesterol (mg/dl) 229.8±15.8 232.5±17.4 231.1±16.3 0.6831)
Normal n (%) 0 (00.00) 0 (00.00) 0 (100.00)
High n (%) 13 (100.00) 13 (100.00) 26 (100.00)
Triglyseride (mg/dl) 183.4±95.6 172.5±72.5 178.0±83.3 0.7471)
Normal n (%) 6 (46.15) 5 (38.46) 11 (42.31)
High n (%) 7 (53.85) 8 (61.54) 15 (57.69)
HDL (mg/dl) 49.4±10.1 41.8±8.7 45.6±10.0 0.0511)
Low n (%) 12 (92.31) 7 (53.85) 19  (73.08)
Normal n (%) 1 (7.69) 6 (46.15) 7 (26.92)
LDL (mg/dl) 132.4±21.7 167.3±45.5 149.8±39.2 0.023*1)
Normal n (%) 1 (7.69) 0 (0.00) 1 (3.85)
High n (%) 12 (92.31) 13 (100.00) 25 (96.15)
1) Independent T-test.2)Mann-Whitneybetweencontrol and intervention group;*significantly in p<0.05
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bias. The analysis result showed that subjects 
at each groups had no significant differences 
(p>0.05) at all characteristics before intervention, 
except for early LDL levels (p<0.05) in which the 
control group had higher LDL level.
The ANCOVA analysis was conducted to 
determine the effect of covariate variables that 
might influence the outcome of changes in lipid 
profile and blood pressure. Covariate variables 
thought to be confounding factors for interven-
tion effect was LDL cholesterol levels before 
intervention as there was significant difference 
bet-ween control and intervention groups. The 
analysis result showed that LDL levels before in-
tervention significantly influenced the LDL levels 
after intervention (p<0.05) and had no significant 
effect to blood pressure or other lipid profile vari-
ables. The negative value of regression coeffi-
cient of estimates on LDL levels changes showed 
the reversed relationship between LDL levels be-
fore intervention and LDL levels decreasing after 
intervention.
The effect of torbangun powder capsule on 
lipid profile
The result of lipid profile analysis showed 
that after treatment (Table 2), the cholesterol lev-
els of intervention group significantly change 
(p<0.05). This result was in line with Viswa-
nathaswamy et al. (2011) and Suryowati et al. 
(2015) statementthat torbangun contained anti-
oxidant component which can lower cholesterol 
levels, but the research results showed differ-
ences with no significant change in triglyceride, 
LDL, and HDL levels (p>0.05). This difference 
was suspected because research of Viswanathas-
wamy et al. (2011) and Suryowati et al. (2015) 
used mice, not human.
After the research, cholesterol levels of 
control group were increased. Lack of antioxi-
dant consumption can lead to increase free radi-
cals which interfere the insulin receptors then af-
fect the metabolism of glucose and fat, that cause 
increasing glucose in the blood and increased li-
polysis in fat tissue (Chang et al. 2013). Research 
from Lipid Research Clinics Coronary Primary 
Prevention Trial (LRCCPPT) in the US pointed 
the relationship between cholesterol lowering 
with risk reduction of coronary heart disease, 
where every 1% decrease in blood cholesterol 
would lower the risk of coronary heart disease as 
much as 2% (Fodor et al. 2000).
There was a decrease in triglyceride and 
LDL levels after taking the torbangun capsule 
intervention for 28 days, although the value was 
not significant. Meanwhile the different test re-
sult showed that there was no significant change 
in cholesterol total, triglyceride, LDL and HDL 
levels.
There were  decrease in HDL level in both 
groups, but in the intervention group, the decreas-
ing of HDL level is lower than control group. 
Base on the ANOVA test, the mean value of LDL 
level change adjusted with the covariat variables 
showed that there was a decrease in LDL level in 
the intervention group, while for control group, 
it was an increase. Non-significant lipid profile 
improvement especially for trigly-ceride, LDL, 
and HDL probably caused by high consump-
tion of carbohydrate and fat (as a common shift 
in Indonesian diet from traditional to an easy to 
prep meals) in which the diet of the participants 
in this study was not controlled. Based on data, 
the average carbohydrate ade-quacy of subjects 
was classified into over-category (≥ 120% of 
individual needs). Erejuwa et al. (2011) stated 
that high consumption of carbohydrate and fat 
caused insulin resistance, which will lead to hy-
pertriglyceridemia and low HDL. In addition. 
non-significant changes were also thought to be 
caused by the less intervention time. Research 
conducted by Baba et al. (2007) regarding plant 
intervention with antioxidant contents especial-
ly polyphenol took longer time (around twelve 
weeks) was proven the reduction of total choles-
terol, LDL, triglyceride, and increasing HDL in 
human.
Tabel 2 .The change of lipid profiles before and after treatment
Variabel
(mg/dl)
Intervention group Control group
p 3
Before After Change p 1 Before After Change p 2
Cholesterol 229.8±95.6 216.8±21.1 -13.0±19.8 0.036* 232.5±17.4 233.9±29.9 1.5±21.9 0.814 0.090
Triglyseride 183.4±95.6 170.0±82.8 -13.4±50.55 0.353 172.5±72.5 164.2±60.0 -8.3±55.8 0.601 0.810
LDL 49.4±10.1 49.2±11.4 -0.2±7.6 0.943 41.8±8.7 40.8±7.2 -1.0±4.4 0.432 0.732
HDL 132.4±21.7 129.1±19.1 -3.3±15.2 0.446 167.3±45.5 160.3±31.7 -7.0±33.4 0.464 0.709
1)Paired t-test between before and after treatment in intervention group; 2) Paired t-test between before and after treatment in 
control group; 3) Independent t-testbetween the change of intervention and control group; *significantly in p<0.05
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Result showed that torbangun leaf has a 
potential as anti-hypercholesterolemia (Yadav et 
al. 2008). It could be expected that the anti-hy-
percholesterolemia effects occurred through inhi-
bition process of HMG-CoA reductase enzyme in 
cholesterol biosynthesis and cholesterol absorp-
tion in small intestine (Sharma et al. 2003). The 
inhibition of cholesterol production would inhibit 
the forming of LDL and increase HDL efficiency 
in blood vessel. HDL as LDL transporter from tis-
sue to liver is excreted by bile. HDL inhibits the 
oxidation of LDL by metal ionic transition and 
12-lipooxygenase in which prevents the forming 
of lipid hydroperoxide. The decreasing of HDL 
levels in the intervention group was thought to 
be a result of the HDL’s activity as an antioxidant 
in transporting cholesterol, it is supported by the 
tendency of decreased levels of LDL in the blood 
(Assmann & Gotto 2004).
The effect of torbangun powder capsule sup-
plementationon to blood pressure
Systolic blood pressure analysis result 
showed that there was a significant difference 
in torbangun capsule consumption during 28 
days (p<0.05) before and after treatment in in-
tervention group (Table 3). There was a decrease 
of -8.5±13.3 mmHg in average. Meanwhile in 
control group, although they experienced the 
decreasing of systolic blood pressure, it was not 
significant (p>0.05). The diastolic blood pressure 
in the intervention group were increasing, mean-
while in control group decreased, but there was 
no significant difference between both groups be-
fore and after intervention.
Blood pressure is the pressure inflicted on 
the artery wall, where peak pressure occurs when 
the ventricle contracts and is called systolic pres-
sure. Diastolic pressure is the lowest pressure 
when blood filling into the heart before being 
pumped throughout the body (the pressure that 
occurs when the heart rests) (Smeltzer & Bare 
2001).
Based on the data above, it could be seen 
that torbangun capsule may decrease systolic 
blood pressure significantly in men with hyper-
cholesterolemia. This was in line with a research 
conducted by Alvianti (2015) that consuming 
torbangun with fish may decrease blood pressure 
significantly compared to consume only fish. 
Moreover, this result was in line with Ardalan 
& Rafieian-Kopaei (2014) who stating that the 
consumption of antioxidant from suplement was 
significantly lowered systolic blood pressure, but 
not significant for diastolic blood pressure. This 
could cause by changes in the fresh ingredients 
into supplement causing antioxidant chains to be 
incompletely available.
Systolic blood pressure decreasing mecha-
nism was thought to be caused by lipid profile 
improvement by decreasing cholesterol, trigly-
ceride, and LDL. So that thickening process of 
artery wall might be halted. Torbangun contains 
flavonoid such as quercetin acting as antioxidant 
which is able to inhibit insulin resistance by re-
pairing pancreatic β cell to prevent hyperglyce-
mia and hyperlipidemia that could cause meta-
bolic syndrome (Suryowati et al. 2015; Chang et 
al. 2013). The thickening of artery wall caused by 
accumulation of lipid plaque might constrict dia-
meter of blood vessel and clog the bloodstream, 
it cause our body need a higher pressure to flow 
the blood throughout the body. The continuousity 
of high blood pressure that caused by accumula-
tion of lipid plaque might omit the elasticity of 
blood vessel, therefore it would be no longer able 
to regulate blood pressure. Thus, heart attack or 
stroke may happened (Erejuwa et al. 2011).
Antioxidant in some vegetables or fruits 
such as polyphenol also play roles in decreas-
ing superoxide dismutase and glutathione per-
oxidase’s activities which may lead to oxidative 
stress, a trigger for hypertension (Baradaran et 
al. 2014). Feryadi et al. (2014) mentioned that 
respondents with high levels of cholesterol had a 
2.09 times higher risk of hypertension than those 
with normal levels.
Tabel 3.The change of blood pressure between before and after treatment
Variabel
(mmHg)
Intervention group Control group
p 3
Before After Change p 1 Before After Change p 2
Sistolic blood 
pressure 137.8±20.6 129.3±17.1 -8.5±13.3 0.039* 142.0±14.3 137.5±13.9 -4.5±9.5 0.111 0.387
Diastolic blood 
pressure 82.2±11.4 83.2±10.8 0.9±9.5 0.732 82.8±9.1 82.4±7.8 -0.4±5.1 0.789 0.667
1)Paired t-test between before and after treatment in intervention group;2) Paired t-test between before and after treatment in 
control group; 3) Independent t-test between the change of intervention and control group; *significantly in p<0.05
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CONCLUSION
Total cholesterol significantly decreased 
after consumption of torbangun capsule as much 
as -11.8 mg/dl after being adjusted with covariate 
variable (p<0.05). Meanwhile, there was no sig-
nificant difference in lipid profile of control group 
(p>0.05). Triglyceride, LDL, and HDL le-vels of 
intervention group did not change significantly 
(p>0.05). However, the torbangun consumption 
showed a tendency to decrease triglyceride and 
LDL levels, meanwhile for the control group they 
experienced an increase of LDL after interven-
tion. Torbangun capsule supplementation also 
significantly decreased the systolic blood pres-
sure (p<0.05) as much as -7.7 mmHg.
Torbangun consumption could be used as 
antioxidant alternative source to help reducing 
the cholesterol level and systolic blood pressure, 
especially in subjects with hypercholesterolemia. 
Analysis of antioxidant contents and torbangun 
leaves potential utilization for health requires in 
further study. Duration of intervention, determi-
nation of dosage used, and addition of control 
group are noteworthy for next study to be consi-
dered. In addition, the measurement of biomarker 
change should be conducted every 7 days or once 
in a week.
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